{"database": "lobbying", "table": "lobbying_activities", "rows": [[784214, "55f327d4-77c4-482f-ad44-abc408c99879", "Q2", "DUTKO WORLDWIDE, LLC", 12868, "GLAXOSMITHKLINE", 2009, "second_quarter", "MMM", "Monitor federal legislation related to medicare and other health care issues and advise client as it affects them, including Patent Reform Act of 2009 (H.R.1260/ S.515/S.610), Budget resolution FY2010 (bill number has not yet been assigned), Pathway for Biosimilars Act (H.R. 1548) & American Recovery and Reinvestment Act of 2009 (HR1) as it relates to comparative effectiveness research funding. Health Care Reform Legislation (to date no specific bills have been introduced). Pharmaceutical import safety legislation.", "HOUSE OF REPRESENTATIVES,SENATE", 40000, null, 0, 0, "2009-07-09T14:30:44-04:00"]], "columns": ["id", "filing_uuid", "filing_type", "registrant_name", "registrant_id", "client_name", "filing_year", "filing_period", "issue_code", "specific_issues", "government_entities", "income_amount", "expense_amount", "is_no_activity", "is_termination", "received_date"], "primary_keys": ["id"], "primary_key_values": ["784214"], "units": {}, "query_ms": 34.38384598121047, "source": "Federal Register API & Regulations.gov API", "source_url": "https://www.federalregister.gov/developers/api/v1", "license": "Public Domain (U.S. Government data)", "license_url": "https://www.regulations.gov/faq"}